查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586192

脂肪團治療市場：按類型、手術類型、最終用途分類 - 2025-2030 年全球預測

Cellulite Treatment Market by Type (Edematous Cellulite, Hard Cellulite, Soft Cellulite), Procedure Type (Minimally Invasive, Non-Invasive, Topical), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年消脂治療市場的市場規模為35.8億美元，預計2024年將達到39.1億美元，複合年成長率為9.59%，到2030年將達到68.1億美元。

由於人們對美容和技術進步的興趣日益濃厚，脂肪團治療市場正在不斷擴大。脂肪團是一種美容狀況，其特徵是由於皮膚表面下的脂肪沉積而導致皮膚出現凹痕，主要影響女性。對脂肪團治療的需求源於人們對美容標準和自我形象的認知不斷提高，迫使人們尋求改善皮膚外觀。此領域的應用範圍從局部治療、雷射治療和射頻等微創手術，到皮下切除等手術選擇。最終用途領域包括皮膚科和美容診所、醫療水療中心以及使用家用設備的家庭護理。

主要市場統計
基準年[2023] 35.8億美元
預測年份 [2024] 39.1億美元
預測年份 [2030] 68.1億美元
複合年成長率（%） 9.59%

推動市場成長的關鍵因素包括可支配收入的增加、健康意識的提高以及提高治療效果和減少停機時間的技術創新。然而，潛在的成長機會在於先進技術的整合，例如人工智慧主導的診斷和治療工具，以及透過非侵入性、負擔得起和易於獲得的選項來擴展產品系列。儘管有這些機會，但市場仍面臨一些限制，例如先進治療的高成本、潛在的副作用和治療功效的可變性，以及可能限制市場進入的嚴格監管要求。

為了掌握市場機遇，公司應專注於研發投資，創新更安全、更有效、更具成本效益的治療方法。與皮膚科醫生合作進行臨床試驗並獲得建議可以進一步提高您產品的可信度。另一個有技術創新空間的領域是利用人工智慧和機器學習來制定適合個人皮膚類型和狀況的個人化治療計劃。此外，全球對遠距皮膚科服務的推動可能會為市場擴張開闢新的途徑，特別是在服務不足的地區。市場競爭激烈且充滿活力，非侵入性解決方案的趨勢凸顯了持續創新以及符合美容和健康消費者趨勢的重要性。

市場動態：揭示快速發展的脂肪團治療市場的關鍵市場洞察

供需的動態交互作用正在改變脂肪團治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 肥胖盛行率上升
    • 消費者對外觀的關注度不斷提高
    • 微創手術受消費者歡迎
  • 市場限制因素
    • 對脂肪團治療的認知與可近性有限
  • 市場機會
    • 開發局部抗脂肪霜和射頻治療
    • 經濟區的醫療旅遊提供負擔得起的整容手術
  • 市場挑戰
    • 手術或治療可能產生的副作用

波特的五力：駕馭脂肪團治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解脂肪團治療市場的外部影響

外部宏觀環境因素在塑造脂肪團治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解脂肪團治療市場的競爭狀況

對脂肪團治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣性消脂治療市場供應商的績效評估

FPNV 定位矩陣是評估脂肪團治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了脂肪團治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對脂肪團治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 肥胖率上升
      • 消費者對外觀的興趣日益濃厚
      • 微創手術受消費者歡迎
    • 抑制因素
      • 對脂肪團治療的認知與可近性有限
    • 機會
      • 開發局部抗脂肪霜和射頻療法
      • 提供負擔得起的整容手術的經濟體的醫療旅遊
    • 任務
      • 手術或治療可能產生的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章脂肪團治療市場：依類型

  • 水腫性脂肪團
  • 硬脂肪團
  • 軟脂肪團

第7章依手術類型分類的脂肪團治療市場

  • 微創
  • 非侵入性
  • 話題

第8章脂肪團治療市場：依最終用途

  • 美容整形外科中心
  • 皮膚科診所
  • 醫院

第9章北美及南美消脂治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太脂肪團治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲消脂治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie, Inc.
  • Alma Lasers Ltd.
  • Beijing Sincoheren S & T Development Co., Ltd.
  • Candela Corporation
  • Cutera, Inc.
  • Cymedics
  • Cymedics GmbH & Co. KG
  • Cynosure, Inc.
  • Endo-Systems LLC
  • Hologic Inc.
  • Inceler Medikal Co. Ltd.
  • Johnson & Johnson Services, Inc.
  • Merz Pharma
  • Merz Pharma GmbH & Co. KGaA
  • Nestle SA
  • Shanghai Fosun Pharmaceutical（Group）Co. Ltd
  • Skinrex Co., Ltd.
  • Venus Concept Inc.
  • Zimmer Aesthetics, Inc.
Product Code: MRR-F927BA4624EC

The Cellulite Treatment Market was valued at USD 3.58 billion in 2023, expected to reach USD 3.91 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 6.81 billion by 2030.

The cellulite treatment market is broadening, driven by increasing aesthetic concerns and technological advancements. Cellulite, a cosmetic condition marked by dimpled skin due to fat deposit beneath the skin's surface, primarily affects women. The necessity for cellulite treatment stems from heightened beauty standards and self-image consciousness, compelling individuals to seek improved skin appearance. Applications in this domain range from topical treatments and minimally invasive procedures like laser therapy and radiofrequency, to surgical options such as subcision. End-use sectors predominantly include dermatological and cosmetic clinics, medical spas, and homecare settings equipped with at-home devices.

KEY MARKET STATISTICS
Base Year [2023] USD 3.58 billion
Estimated Year [2024] USD 3.91 billion
Forecast Year [2030] USD 6.81 billion
CAGR (%) 9.59%

Key factors driving market growth include rising disposable incomes, an increase in health and wellness awareness, and technological innovations offering enhanced treatment efficacy and reduced downtime. However, potential growth opportunities lie in integrating advanced technologies like AI-driven diagnostic and treatment tools, and expanding product portfolios with non-invasive, affordable, and accessible options. Despite these opportunities, the market faces constraints such as high costs of advanced treatments, possible side effects and varied treatment efficacy, and stringent regulatory requirements that may limit market access.

To capitalize on market opportunities, companies should focus on R&D investments to innovate safer, more effective, and cost-efficient treatments. Collaborations with dermatologists for clinical trials and gaining endorsements can further bolster product credibility. Another area ripe for innovation is personalized treatment plans that cater to individual skin types and conditions, leveraging AI and machine learning for precise customization. Furthermore, the global push towards tele-dermatology services could open new avenues for market expansion, especially in underserved regions. The nature of the cellulite treatment market is competitive and dynamic, with a trend towards non-invasive solutions, highlighting the importance of continuous innovation and alignment with consumer trends in beauty and wellness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cellulite Treatment Market

The Cellulite Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the prevalence of obesity
    • Increasing consumer focus on physical appearance
    • Popularity of minimally invasive procedures among consumers
  • Market Restraints
    • Limited awareness and accessibility of cellulite treatments
  • Market Opportunities
    • Development of topical anti-cellulite creams and radiofrequency therapy
    • Medical tourism in economies delivering affordable aesthetic surgical procedures
  • Market Challenges
    • Possible side effects of surgeries and procedures

Porter's Five Forces: A Strategic Tool for Navigating the Cellulite Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cellulite Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cellulite Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cellulite Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cellulite Treatment Market

A detailed market share analysis in the Cellulite Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cellulite Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cellulite Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cellulite Treatment Market

A strategic analysis of the Cellulite Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cellulite Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Alma Lasers Ltd., Beijing Sincoheren S & T Development Co., Ltd., Candela Corporation, Cutera, Inc., Cymedics, Cymedics GmbH & Co. KG, Cynosure, Inc., Endo-Systems LLC, Hologic Inc., Inceler Medikal Co. Ltd., Johnson & Johnson Services, Inc., Merz Pharma, Merz Pharma GmbH & Co. KGaA, Nestle S.A., Shanghai Fosun Pharmaceutical (Group) Co. Ltd, Skinrex Co., Ltd., Venus Concept Inc., and Zimmer Aesthetics, Inc..

Market Segmentation & Coverage

This research report categorizes the Cellulite Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Edematous Cellulite, Hard Cellulite, and Soft Cellulite.
  • Based on Procedure Type, market is studied across Minimally Invasive, Non-Invasive, and Topical.
  • Based on End-Use, market is studied across Cosmetic Surgery Centers, Dermatology Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the prevalence of obesity
      • 5.1.1.2. Increasing consumer focus on physical appearance
      • 5.1.1.3. Popularity of minimally invasive procedures among consumers
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and accessibility of cellulite treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of topical anti-cellulite creams and radiofrequency therapy
      • 5.1.3.2. Medical tourism in economies delivering affordable aesthetic surgical procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Possible side effects of surgeries and procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cellulite Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Edematous Cellulite
  • 6.3. Hard Cellulite
  • 6.4. Soft Cellulite

7. Cellulite Treatment Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Minimally Invasive
  • 7.3. Non-Invasive
  • 7.4. Topical

8. Cellulite Treatment Market, by End-Use

  • 8.1. Introduction
  • 8.2. Cosmetic Surgery Centers
  • 8.3. Dermatology Clinics
  • 8.4. Hospitals

9. Americas Cellulite Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cellulite Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cellulite Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Alma Lasers Ltd.
  • 3. Beijing Sincoheren S & T Development Co., Ltd.
  • 4. Candela Corporation
  • 5. Cutera, Inc.
  • 6. Cymedics
  • 7. Cymedics GmbH & Co. KG
  • 8. Cynosure, Inc.
  • 9. Endo-Systems LLC
  • 10. Hologic Inc.
  • 11. Inceler Medikal Co. Ltd.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Merz Pharma
  • 14. Merz Pharma GmbH & Co. KGaA
  • 15. Nestle S.A.
  • 16. Shanghai Fosun Pharmaceutical (Group) Co. Ltd
  • 17. Skinrex Co., Ltd.
  • 18. Venus Concept Inc.
  • 19. Zimmer Aesthetics, Inc.

LIST OF FIGURES

  • FIGURE 1. CELLULITE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CELLULITE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELLULITE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELLULITE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY EDEMATOUS CELLULITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HARD CELLULITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY SOFT CELLULITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COSMETIC SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023